Tuesday, September 29, 2009
A Young Man Transitioning and Changing To A pH Miracle Life
Will Coffee, Beer, Cola, or Alkaline Water Light Up Dr. Young's Light?
Here is the link to view Dr. Young's latest experiment on cola drinks, coffee, beer and alkaline water:
http://www.youtube.com/watch?v=3vm_ZnZymoI
Monday, September 28, 2009
Vitamin D Deficiency May Lead To High Blood Pressure
The study, presented at a meeting of the American Heart Association in Chicago, adds younger women to a growing list of people including men who may develop high blood pressure at least in part because of low vitamin D.
Researchers in Michigan, who examined data on 559 women beginning in 1992, found that those with low levels of vitamin D were more likely to have high blood pressure 15 years later in 2007.
"Our results indicate that early vitamin D deficiency may increase the long-term risk of high blood pressure in women at mid-life," said Flojaune Griffin, who worked on the study for the University of Michigan School of Public Health.
Vitamin D, which the human body can make from sunlight and which is found in fatty fish, and dietary supplements, has long been known to contribute to healthy bones and teeth.
But Vitamin D deficiencies, which are widespread in women, are linked to cancer, immune system problems and inflammatory diseases.
High blood pressure raises the likelihood of stroke, heart disease and other cardiovascular problems.
The women in the blood pressure study lived in Tecumseh, Michigan, and were 24 to 44 years old with an average age of 38, when the research began.
Researchers measured vitamin D blood levels at the outset and took blood pressure readings once a year. In 2007, they compared systolic readings -- the top number in blood pressure results that indicates the pressure within blood vessels when the heart beats.
More than 10 percent of women with vitamin D deficiencies had high blood pressure in 2007, versus 3.7 percent of those with sufficient levels. When the study began, 5.5 percent with deficiencies also had high blood pressure, compared to 2.8 percent with normal vitamin D.
The study was funded by the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Almost half the population worldwide has lower-than-optimal levels of vitamin D and researchers say the problem is worsening as people spend more time indoors. African-Americans seem at especially high risk as dark skin can make it harder for the body to absorb ultraviolet light.
According to Dr. Robert O. Young, Director of Research at the pH Miracle Living Center, "Vitamin D helps to reduce dietary and metabolic acid that leads immune deficiency, bone loss, hypertension and even a cancerous acidic condition. To protect yourself against acids that can make you sick and tired you need at least 50,000 I.U's of Vitamin D3 daily."
http://www.phmiracleliving.com/p-404-ph-d3.aspx
In Love and Healing Light,
Robert O. Young, Ph.D., D.Sc.
Founder of 'THE NEW BIOLOGY' ®
Creator of the 'SCIENCE OF ALKALINE
LIVING'™ for Health.
Sunday, September 27, 2009
Bollywood Beauties Unseen Hot Photos, Pics, Wallpapers
The Beauties are Mallika Sherawat, Shilpa Shetty, Celina Jailtley, Aishwarya Rai, Kareena Kapoor, Amrita Arora, Shamita Shetty, Neha Dhupia, Bipasha Basu, Priyanka Chopra & Katrina Kaif which i like to share with you. Get latest rare unseen rare unseen hot photos, pics, wallpapers of bollywood beauties, popular bollywood actress, top hottest bollywood actresses, beautiful bollywood actresses, top sexy bollywood actresses.
















Saturday, September 26, 2009
Testicular and Lung Cancer at the Age of 33
Only 10 Percent of Adults Have Low Risk For Heart Attack
What Causes Human Papilloma Cancer HPV
Wednesday, September 23, 2009
The Pleomorphic Nature of Morgellons Syndrome
We report a possible basis of differentiation, based on the biophysical properties of fibers isolated from a Morgellons patient, as well as a future avenue of study for isolating the cause of Morgellons.
II. Discussion
A: Fiber Analysis
Fibers, upon inspection, were found to be fluorescent. The pictures (Figure 1A, 1B) show both a fiber and a hair sample from the same patient observed under white light and a Hofstead filter (with 365 excitiation). The fibers were visualized in scintillation vials with a Innotech detector, showing fluorescence with both a Hofstead filter (460 nm)and a green fluorescent filter (SYBR Green, 557 nm) upon excitation at both 305 and 365 nm. The fluorescence ceased after the illumination was extinquished. A single fiber is shown in Figure 1C.
The fiber shown in 1C was examined via SEM Microscopy at the University of Northern Arizona, with no additional modifications or treatments. SEM analysis demonstrated that the fiber appeared to be a normal hair follicle with scales (Figure 2A) and a typical root terminus (Figure 2B). The absence of a smooth surface denotes that the fiber does not seem to be coated with a protein monolayer.
In order to quantify the nature of the fluorescence, a cluster of fibers placed in nanopure deionized water were observed via a Hitachi Fluorometer. When observing the fibers, a characteristic fluorescent pattern emerged. This fluorescence pattern would account for fluorescence seen in the published pictures at the Morgellons research foundation web site. A fluorescent factor (protein) was isolated as described below, and found to have a similar pattern of fluorescence. The cuvette alone did not fluoresce, but an equivalent protein concentration of BSA (bovine serum albumin) gave a fluorescence which differed distinctly from the fiber fluorescence (potentially eliminating bovine albumin as a protein identity). Figure 3 shows the fluorescence observed.
Figure 1A: Fiber (top) and hair (bottom) viewed with white light

Figure 1B: Fiber top) and hair (bottom ) viewed with Hofstead filter (360 excitation with transilluminator)

Figure 1C: Single Fiber viewed with Hofstead filter and 360 excitation

Figure 2A: SEM of fiber body

Figure 2B: SEM of fiber root

Figure 3: (click here for the Fluorescence part of the report)
B. Fiber protein composition
Fibers from a patient with Morgellons Syndrome resisted dissolution in 6 M guandidine HCL, 6 M urea, and Trizol (Sigma) reagent. Fibers were ground in a mortar and pestle and resuspended in 2X SDS Buffer, and run on a 4-20% Tris Glycine Gel. Gel was coomassie stained and destained as described in Mantiatis (1998). 30 kDa, 60 kDa, protein bands were observed. (Figure 4, Lane 5). The predominant band was identified (from gel excision and in gel digest/nanoHPLC/MS at the University of Arizona Proteonomics Laboratory) as human serum albumin and cytoskeletal keratin II (67 kDa) with significant peptide fragment coverage over both protein sequences.
The fluorescent factor was isolated as a soluble component, and demonstrated to be a molecule of molecular weight greater than 10 kDa (through both dialysis and ultrafiltrations in Amicon Ultra 15 devices). (Isolation was simple: The gel running buffer in which the above protein samples were run in were found to be fluorescent. Incidently, the addition of GHCl to the SDS samples served to precipitate protein into a fibrillar format Buffer was filtered and purified via a C18 column (Waters C18 Sep-Pak)
Both a UV-Vis spectra of the buffer containing the fluorescent factor and a positive Bradford assay result confirmed that the fluorescent factor contained a protein component. Gel analysis of the fluorescent factor protein component demonstrated a protein with a molecular weight of 30 kDa, also found in the analysis of the entire fiber.
Interestingly enough, a similar nano-HPLC/MS analysis of this 30 kDa protein produced no human protein peak comparisons, and only single peptide fragments potentially corresponding to the following proteins (with approximate molecular weights corresponding to 30-40 kDa) were identified (Table 1). It may be noteworthy that the U/Az facility could not purify the protein using conventional methods from the buffer. Reportedly, a black tar-like oil precipitated under their assay conditions. This may denote other molecules that were potentially present in the buffer, originating from the fiber protein mixture.
Table 1: Peptide Fragment Listing for 30 kDa fluorescence associated protein
gi|225632m(casein alpha S1) bovine origin |
gi|56477959m(probable iron-sulfur 4Fe-4S ferredoxin protein [Azoarcus sp. EbN1]_gi|56314002|emb|CAI08647.1| probable iron-sulfur 4Fe-4S ferredoxin protein [Azoarcus sp. EbN1]) |
gi|55420470probable alkene monooxygenase reductase [Nocardioides sp. JS614] |
gi|34102607conserved hypothetical protein [Chromobacterium violaceum ATCC 12472]_gi|34496752|ref|NP_900967.1| hypothetical protein CV1297 [Chromobacterium violaceum ATCC 12472] |
gi|68351715hypothetical protein TP02_0195 [Theileria parva] |
gi|53689178COG0458: Carbamoylphosphate synthase large subunit (split gene in MJ) [Leuconostoc mesenteroides subsp. mesenteroides ATCC 8293] |


III. Future direction:
The fluorescent factor protein was purified via C18 Sep-Pak chromatography, eluted with methanol/water (50:50) and rotary evaporated to dryness. The resultant powder should be sent to OSU Stillwater’s Proteonomic facility for MALDI-TOF and Edmund sequence analysis. MALDI-TOF will allow the identification of the exact mass of one (or several) proteins in the mixture, whereas Edmund sequence analysis will yield the first fifteen amino acids present in the protein sequence, allowing for either confirmation of the prior nano-HPLC/MS results or bioinformatics searches to obtain the protein identity. As of now, the samples have been sent to Dr. Wymore, due to complications with communicating with the Stillwater facility. Currently, this protein identity is unknown.
The fluorescence (associated with fibers), isolated to a protein composition, may be a unique feature to Morgellons patetients. The establishment of a diagnostic biochemical characteristic to Morgellons would greatly assist clinical practicioners in distinguishing between Morgellons and Delusional Parasitosis. Accordingly, it may be of significant interest to screen a wide variety of fibers from Morgellons patients for fluorescence, in order to establish this as a feature common to many patients. Similarly, it may be of interest to survey textile and cellulose fibers for fluorescence, in order to establish the fluorescent fiber hallmark as a unique, non-commerical, non-man-made entity. Further protein analysis of the fluorescent factor may yield clues to the infectious agent idenitity, as the protein does not, in this single sample, correspond to any potential human gene or protein product.
The techniques described here could also be applied to another physical manifestation of Morgellons: the emergence of black “specks” from the skin. A similar protein biochemical analysis of the specks may prove revealing in identifying the entity responsible for Morgellons.
Regardless, it must be emphasized that this is the sum result of a single patient with Morgellons, and thus not statistically accurate/valid as a potential portrayal of the Morgellons condition. Multiple analyses need to be conducted on multiple fibers from multiple patients, before this information should be scientifically reported.
Monday, September 21, 2009
Chlorophyll, Chlorophyllin and Selenium in Reversing A Cancerous Condition
Research from the Linus Pauling Institute at Oregon State University suggests that natural compounds of chlorophyll, chlorophyllin, and selenium compounds, which previously have been studied for their ability to preventing a cancerous condition, may be able to play a more significant role in reversing a cancerous condition.
A new study just published in the International Journal of Cancer examined the activity of chlorophyllin and found that, on a dose-by-dose basis, it was 10 times more potent at causing death of colon cancer cells than hydroxyurea, a chemotherapeutic drug commonly used in cancer treatment.
Beyond that, chlorophyllin kills cancer cells by blocking the same phase of cellular division that hydroxyurea does, but by a different mechanism. This suggests that it – and possibly other “cocktails” of natural products – might be developed to have a synergistic effect with conventional cancer drugs, helping them to work better or require less toxic dosages, researchers said.
“We conclude that chlorophyllin has the potential to be effective in the clinical setting, when used alone or in combination with currently available cancer therapeutic agents,” the researchers wrote in their study.
The concept of combining conventional or new cancer drugs with natural compounds that have been shown to have anti-cancer properties is very promising, said Rod Dashwood, professor and director of the Cancer Chemoprotection Program in the Linus Pauling Institute.
“Most chemotherapeutic approaches to cancer try to target cancer cells specifically and do something that slows or stops their cell growth process,” Dashwood said. “We’re now identifying such mechanisms of action for natural compounds, including dietary agents. With further research we may be able to make the two approaches work together to enhance the effectiveness of cancer therapies.”
Chlorophyllin is a water-soluble derivative of chlorophyll – the green pigment found in most plants and many food products that makes possible the process of photosynthesis and plant growth from the sun’s energy. Chlorophyllin is inexpensive, and animal studies plus human clinical data suggest that it can be ingested at relatively high levels without toxicity.
In the new study, researchers found that pharmacologic doses of chlorophyllin caused colon cancer cells to spend more time than normal in their “synthesis phase” in which DNA is duplicated. Timing is critical to the various phases of cell growth, researchers said, and this disruption started a process that ultimately led to cell death, the study found.
In particular, the presence of high levels of chlorophyllin caused a major reduction in the level of ribonucleotide reductase, an enzyme critical to DNA synthesis, researchers found. This is also the mechanism of action of hydroxyurea, one drug already being used for cancer chemotherapy.
“In cancer research right now there’s interest in approaches that can reduce ribonucleotide reductase,” Dashwood said. “At the doses used in our experiments, chlorophyllin almost completely stops the activity of this enzyme.”
Further research is needed both in laboratory and animal studies, with combinations of chlorophyllin and existing cancer drugs, before it would be appropriate for human trials, Dashwood said. Chlorophyllin, in general, is poorly absorbed from the human gastrointestinal tract, so it’s unclear what levels might be needed for therapeutic purposes or how well they would work.
Other dietary agents also might have similar potential. Work just published by LPI researchers in the journals Carcinogenesis and Cancer Prevention Research explored the role of organic selenium compounds in killing human prostate and colon cancer cells. Colorectal and prostate cancers are consistently among the leading causes of cancer mortality in the United States, and will account respectively for 18 percent and 9 percent of all cancer deaths in 2009, according to estimates from the American Cancer Society.
In the recent studies, a form of organic selenium found naturally in garlic and Brazil nuts was converted in cancer cells to metabolites that acted as “HDAC inhibitors” – a promising field of research in which silenced tumor suppressor genes are re-activated, triggering cancer cell death.
“Whether it’s HDAC inhibition leading to one manner of cancer cell growth arrest, or loss of ribonucleotide reductase activity leading to another, as seen with chlorophyllin, there’s significant promise in the use of natural products for combined cancer therapies,” Dashwood said. “These are areas that merit continued research.”
These studies were supported by the National Cancer Institute and the National Institute of Environmental Health Sciences. Other collaborators included researchers from the New York Medical College and the Penn State College of Medicine.
Chlorophyll is identical to your hemoglobin except for the center atom. Dr. Robert O. Young's, at the pH Miracle Living Center in San Diego, California suggests, "as one increases their consumption of chlorophyll from green foods and green drinks the quality and quantity of the red blood cells improve. This can be noted on a CBC medical test as the red blood cell count increases and the hemoglobin increases to a healthy range. Liquid chlorophyll and chlorophyllin can be added to any water or green drink to improve the concentration of this powerful blood building compound."http://www.phmiracleliving.com/p-306-liquid-chloropheal-4-oz.aspx
References: Chlorophyll and Chlorophyllin
1. Matthews CK, van Holde KE. Biochemistry. 2nd ed. Menlo Park: The Benjamin/Cummings Publishing Company; 1996.
2. Sudakin DL. Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review. J Toxicol Clin Toxicol. 2003;41(2):195-204. (PubMed)
3. Dashwood RH. The importance of using pure chemicals in (anti) mutagenicity studies: chlorophyllin as a case in point. Mutat Res. 1997;381(2):283-286. (PubMed)
4. Egner PA, Stansbury KH, Snyder EP, Rogers ME, Hintz PA, Kensler TW. Identification and characterization of chlorin e(4) ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial. Chem Res Toxicol. 2000;13(9):900-906. (PubMed)
5. Tachino N, Guo D, Dashwood WM, Yamane S, Larsen R, Dashwood R. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat Res. 1994;308(2):191-203. (PubMed)
6. Dashwood R, Yamane S, Larsen R. Study of the forces of stabilizing complexes between chlorophylls and heterocyclic amine mutagens. Environ Mol Mutagen. 1996;27(3):211-218. (PubMed)
7. Breinholt V, Schimerlik M, Dashwood R, Bailey G. Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen. Chem Res Toxicol. 1995;8(4):506-514. (PubMed)
8. Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003;523-524:209-216. (PubMed)
9. Kumar SS, Devasagayam TP, Bhushan B, Verma NC. Scavenging of reactive oxygen species by chlorophyllin: an ESR study. Free Radic Res. 2001;35(5):563-574. (PubMed)
10. Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta. 2000;1487(2-3):113-127. (PubMed)
11. Park KK, Park JH, Jung YJ, Chung WY. Inhibitory effects of chlorophyllin, hemin and tetrakis(4-benzoic acid)porphyrin on oxidative DNA damage and mouse skin inflammation induced by 12-O-tetradecanoylphorbol-13-acetate as a possible anti-tumor promoting mechanism. Mutat Res. 2003;542(1-2):89-97. (PubMed)
12. Kumar SS, Shankar B, Sainis KB. Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo. Biochim Biophys Acta. 2004;1672(2):100-111. (PubMed)
13. Yun CH, Jeong HG, Jhoun JW, Guengerich FP. Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis. 1995;16(6):1437-1440. (PubMed)
14. Dingley KH, Ubick EA, Chiarappa-Zucca ML, et al. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer. 2003;46(2):212-221. (PubMed)
15. Chimploy K, Diaz GD, Li Q, et al. Int J Cancer. 2009; in press.
16. Dashwood RH, Breinholt V, Bailey GS. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay. Carcinogenesis. 1991;12(5):939-942. (PubMed)
17. Kensler TW, Groopman JD, Roebuck BD. Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. Mutat Res. 1998;402(1-2):165-172. (PubMed)
18. Simonich MT, Egner PA, Roebuck BD, et al. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat. Carcinogenesis. 2007;28(6):1294-1302. (PubMed)
19. Breinholt V, Hendricks J, Pereira C, Arbogast D, Bailey G. Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout. Cancer Res. 1995;55(1):57-62. (PubMed)
20. Orner GA, Roebuck BD, Dashwood RH, Bailey GS. Post-initiation chlorophyllin exposure does not modulate aflatoxin-induced foci in the liver and colon of rats. J Carcinog. 2006;5:6. (PubMed)
21. Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994;3(1):3-10. (PubMed)
22. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001;98(25):14601-14606. (PubMed)
23. Chernomorsky SA, Segelman AB. Biological activities of chlorophyll derivatives. N J Med. 1988;85(8):669-673. (PubMed)
24. Siegel LH. The control of ileostomy and colostomy odors. Gastroenterology. 1960;38:634-636. (PubMed)
25. Weingarten M, Payson B. Deodorization of colostomies with chlorophyll. Rev Gastroenterol. 1951;18(8):602-604.
26. Christiansen SB, Byel SR, Stromsted H, Stenderup JK, Eickhoff JH. [Can chlorophyll reduce fecal odor in colostomy patients?]. Ugeskr Laeger. 1989;151(27):1753-1754. (PubMed)
27. Young RW, Beregi JS, Jr. Use of chlorophyllin in the care of geriatric patients. J Am Geriatr Soc. 1980;28(1):46-47. (PubMed)
28. Yamazaki H, Fujieda M, Togashi M, et al. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci. 2004;74(22):2739-2747. (PubMed)
29. Kephart JC. Chlorophyll derivatives - their chemistry, commercial preparation and uses. Econ Bot. 1955;9:3-38.
30. Bowers WF. Chlorophyll in wound healing and suppurative disease. Am J Surg. 1947;73:37-50.
31. Carpenter EB. Clinical experiences with chlorophyll preparations. Am J Surg. 1949;77:167-171.
32. 2004 Physicians' Desk Reference. 58th ed. Stamford: Thomson Health Care, Inc.; 2003.
33. Smith RG. Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage. 2008;54(8):16-34. (PubMed)
34. Weir D, Farley KL. Relative delivery efficiency and convenience of spray and ointment formulations of papain/urea/chlorophyllin enzymatic wound therapies. J Wound Ostomy Continence Nurs. 2006;33(5):482-490. (PubMed)
35. Bohn T, Walczyk S, Leisibach S, Hurrell RF. Chlorophyll-bound magnesium in commonly consumed vegetables and fruits: relevance to magnesium nutrition. J Food Sci. 2004;69(9):S347-S350.
36. GPO Access. Electronic Code of Federal Regulations: Miscellaneous Internal Drug Products for Over the Counter Use. [Web page]. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=
6bb427d78a48e3983e0456d15a058c40&rgn=div6&view=text&node=
21:5.0.1.1.27.5&idno=21. Accessed June 4, 2009.
37. GPO Access. Electronic Code of Federal Regulations: Listing of Color Additives Exempt from Certification [Web page]. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=
090fc8b3dcd5f08075f3d2d0c2654073&rgn=div8&view=text&node=
21:1.0.1.1.26.3.31.7&idno=21. Accessed June 4, 2009.
38. Hendler SS, Rorvik DR, eds. PDR for Nutritional Supplements. 2nd ed. Montvale: Physicians' Desk Reference, Inc; 2008.
39. Smith LW. The present status of topical chlorophyll therapy. N Y State J Med. 1955;55(14):2041-2050. (PubMed)
40. Gogel HK, Tandberg D, Strickland RG. Substances that interfere with guaiac card tests: implications for gastric aspirate testing. Am J Emerg Med. 1989;7(5):474-480. (PubMed)
Sunday, September 20, 2009
Mourning Can Lead To Cardiac Arrest
Grieving people are at significantly higher risk of heart problems, according to a Heart Foundation study of the physical changes suffered immediately after a profound loss, lead researcher Thomas Buckley said on Tuesday.
"We found higher blood pressure, increased heart rate and changes to immune system and clotting that would increase the risk of heart attack," Buckley said.
Half of the 160 people studied were mourning the loss of a partner or child, and their risk of heart attack increased six-fold, he said. The risk, which was evident in people as young as 30, reduced after six months and leveled out after two years.
A sudden flood of acidic stress hormones is believed to be behind the grief-induced heartache, a condition that earlier studies have found is more likely to affect women.
According to Dr. Robert O. Young, Director of the pH Miracle Living Center, "the mourning of a loved one requires energy which results in excess metabolic acid. If the acidic waste products from the sadness is not eliminated through the four channels of elimination, they can make one sick and even cause death - even a heart attack I refer to as a thought attack."
Chronic Acidic Inflammation Reduced and/or Eliminated With Bicarbonates
From Fat to Chronic Inflammation
(Ivanhoe Newswire) -- Chronic inflammation within fat tissue is now recognized as a contributor to the many negative consequences that come with obesity -- from diabetes to cardiovascular disease, according to Yuichi Oike of Kumamoto University in Japan. Researchers hope a new discovery will point to a targeted therapy designed to limit the impact of the obesity epidemic.
The new culprit Oike's team identified is a fat-derived protein called angiopoietin-like protein 2 (Angptl2). In mice, Angptl2 levels are elevated in many organs, but especially in fat tissue. Those levels increase further under the oxygen-deprived conditions typically found within obese fat tissue. Researchers also found higher Angptl2 levels in the blood of humans with higher body mass index and insulin levels.
Obese mice lacking Angptl2 show less inflammation in their fat tissue and are less insulin resistant, researchers report. Likewise, otherwise healthy mice made to have higher than normal Angptl2 levels in their fat tissue develop inflammation and insulin resistance.
The researchers conclude that Angptl2 is a key adipocyte-derived inflammatory mediator linking obesity to systemic insulin resistance, and they have identified it as a new molecular target that could be used to improve the diagnosis and treatment of obesity and related metabolic diseases.
Oike is quoted as saying he thinks drugs that would act on Angptl2 not only have considerable promise, but are also likely to come with limited side effects.
"In healthy animals and people, the precise role of Angptl2 has not been clarified," he said. "However, mice in which Angptl2 was deleted genetically were born normally and showed normal growth compared to genetically normal mice. Therefore, we speculate that the possibility of the occurrence of a serious unfavorable side effect due to treatments that decrease Angptl2 expression in animals or people is low."
SOURCE: Cell Metabolism, September, 2009
Reference: http://ivanhoe.com/channels/p_channelstory.cfm?storyid=22364